Presentation AHA 2016 PIONEER Trial: An OPen-label, Randomized, Controlled, Multicenter Study ExplorIng TwO TreatmeNt StratEgiEs of Rivaroxaban and a Dose-Adjusted Oral Vitamin K Antagonist Treatment Strategy Presenter: Michael Gibson November 15, 2016 REGISTER for free or LOG IN to view this content Coronary Cardiac Surgery Heart Rhythm Atrial Fibrillation Presentation AHA 2016 We Recommend